4-78516001-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BA1

The NM_025074.7(FRAS1):​c.10377C>T​(p.Thr3459Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 1,611,934 control chromosomes in the GnomAD database, including 25,924 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T3459T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.19 ( 2692 hom., cov: 32)
Exomes 𝑓: 0.18 ( 23232 hom. )

Consequence

FRAS1
NM_025074.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.67

Publications

13 publications found
Variant links:
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
  • Fraser syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Fraser syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.208).
BP6
Variant 4-78516001-C-T is Benign according to our data. Variant chr4-78516001-C-T is described in ClinVar as Benign. ClinVar VariationId is 261795.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.67 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRAS1NM_025074.7 linkc.10377C>T p.Thr3459Thr synonymous_variant Exon 66 of 74 ENST00000512123.4 NP_079350.5 Q86XX4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRAS1ENST00000512123.4 linkc.10377C>T p.Thr3459Thr synonymous_variant Exon 66 of 74 5 NM_025074.7 ENSP00000422834.2 Q86XX4-2

Frequencies

GnomAD3 genomes
AF:
0.185
AC:
28199
AN:
152072
Hom.:
2690
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.134
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.141
Gnomad FIN
AF:
0.201
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.182
Gnomad OTH
AF:
0.189
GnomAD2 exomes
AF:
0.180
AC:
44314
AN:
246138
AF XY:
0.179
show subpopulations
Gnomad AFR exome
AF:
0.184
Gnomad AMR exome
AF:
0.138
Gnomad ASJ exome
AF:
0.265
Gnomad EAS exome
AF:
0.235
Gnomad FIN exome
AF:
0.200
Gnomad NFE exome
AF:
0.183
Gnomad OTH exome
AF:
0.173
GnomAD4 exome
AF:
0.177
AC:
258534
AN:
1459744
Hom.:
23232
Cov.:
33
AF XY:
0.176
AC XY:
127810
AN XY:
725986
show subpopulations
African (AFR)
AF:
0.192
AC:
6422
AN:
33442
American (AMR)
AF:
0.143
AC:
6395
AN:
44568
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
6821
AN:
26108
East Asian (EAS)
AF:
0.212
AC:
8375
AN:
39590
South Asian (SAS)
AF:
0.144
AC:
12392
AN:
85996
European-Finnish (FIN)
AF:
0.205
AC:
10964
AN:
53356
Middle Eastern (MID)
AF:
0.222
AC:
1279
AN:
5762
European-Non Finnish (NFE)
AF:
0.175
AC:
194391
AN:
1110602
Other (OTH)
AF:
0.191
AC:
11495
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
10671
21342
32013
42684
53355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6936
13872
20808
27744
34680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.185
AC:
28208
AN:
152190
Hom.:
2692
Cov.:
32
AF XY:
0.186
AC XY:
13859
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.186
AC:
7738
AN:
41514
American (AMR)
AF:
0.169
AC:
2590
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
933
AN:
3472
East Asian (EAS)
AF:
0.232
AC:
1198
AN:
5164
South Asian (SAS)
AF:
0.140
AC:
677
AN:
4826
European-Finnish (FIN)
AF:
0.201
AC:
2129
AN:
10594
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.182
AC:
12349
AN:
68004
Other (OTH)
AF:
0.187
AC:
395
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1203
2406
3609
4812
6015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.176
Hom.:
2162
Bravo
AF:
0.183
Asia WGS
AF:
0.207
AC:
721
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fraser syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.28
DANN
Benign
0.45
PhyloP100
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3749487; hg19: chr4-79437155; COSMIC: COSV53606678; API